Skip to Content

iShares Paris-Aligned ClmMSCIWldExUSAETF PABD

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis PABD

Will PABD outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin iShares Paris-Aligned ClmMSCIWldExUSAETF's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PABD

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.39 1.3 Mil
Healthcare

ASML Holding NV

2.11 1.2 Mil
Technology

Schneider Electric SE

1.64 906,675
Industrials

Tokyo Electron Ltd

1.43 789,512
Technology

Lvmh Moet Hennessy Louis Vuitton SE

1.31 724,037
Consumer Cyclical

ABB Ltd

1.29 710,849
Industrials

AstraZeneca PLC

1.28 705,845
Healthcare

Novartis AG Registered Shares

1.22 671,980
Healthcare

SAP SE

1.14 628,408
Technology

Roche Holding AG

1.06 586,574
Healthcare